Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
33.98
-1.23 (-3.49%)
Nov 17, 2026, 3:00 PM CST

Evopoint Biosciences Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
2,248761.04300.27230.46117.76
Short-Term Investments
----28.52
Trading Asset Securities
331.957.3683.16300.01283.09
Cash & Short-Term Investments
2,579818.39383.42530.47429.37
Cash Growth
-113.44%-27.72%23.55%-
Other Receivables
1.792.181.4310.971.22
Receivables
1.982.181.4310.971.22
Other Current Assets
82.5590.9841.8522.0816.54
Total Current Assets
2,664911.55426.71563.52447.13
Property, Plant & Equipment
445.69429.4434.28411.29301.57
Long-Term Investments
377.3334.32178.48124.6113.82
Other Intangible Assets
7.778.869.018.968.92
Long-Term Deferred Charges
0.220.294.198.6714.07
Other Long-Term Assets
114.4458.3635.6119.5330.62
Total Assets
3,6091,7431,0881,137916.13

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
153.0197.2297.3652.0349.77
Accrued Expenses
24.8121.3228.9825.5618.43
Short-Term Debt
-0.7-30.0255.05
Current Portion of Long-Term Debt
416.03159.67116.4928.149.13
Current Portion of Leases
-10.017.348.6110.8
Other Current Liabilities
17.6219.9960.3158.5727.91
Total Current Liabilities
613.68308.91310.47202.93171.09
Long-Term Debt
893.49713.86397.65338.7268.46
Long-Term Leases
8.7714.01-6.7517.23
Long-Term Unearned Revenue
2.722.9820.79.15-
Total Liabilities
1,5191,040728.82557.54456.78

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
435.49370.17370.1736052.73
Additional Paid-In Capital
3,4001,7821,6411,4841,245
Retained Earnings
-1,745-1,449-1,652-1,266-838.95
Comprehensive Income & Other
-0.040.530.250.890.39
Shareholders' Equity
2,091703.03359.46579.02459.35
Total Liabilities & Equity
3,6091,7431,0881,137916.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
1,318898.25521.48412.22360.67
Net Cash (Debt)
1,261-79.86-138.05118.2468.7
Net Cash Growth
---72.11%-
Net Cash Per Share
3.40-0.22-0.380.350.21
Filing Date Shares Outstanding
435.49370.17370.17341.51325.8
Total Common Shares Outstanding
435.49370.17370.17341.51325.8
Working Capital
2,050602.64116.24360.59276.04
Book Value Per Share
4.801.900.971.701.41
Tangible Book Value
2,083694.17350.45570.06450.43
Tangible Book Value Per Share
4.781.880.951.671.38
Buildings
-265.41---
Machinery
-206.24---
Construction In Progress
-2.31---